tiprankstipranks
Annexin Pharmaceuticals AB (SE:ANNX)
:ANNX
Sweden Market
ANNX
Annexin Pharmaceuticals AB
RESEARCH TOOLSreports
Want to see SE:ANNX full AI Analyst Report?

Annexin Pharmaceuticals AB (ANNX) Financial Statements

2 Followers

Annexin Pharmaceuticals AB Financial Overview

Annexin Pharmaceuticals AB's market cap is currently kr112.46M. The company's EPS TTM is kr-4.4149; its P/E ratio is -2.92; Annexin Pharmaceuticals AB is scheduled to report earnings on February 5, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profitkr -48.00Kkr -193.00Kkr -193.00Kkr -193.00Kkr -192.00K
Operating Incomekr -36.31Mkr -50.48Mkr -44.18Mkr -40.72Mkr -51.23M
EBITDAkr -36.84Mkr -50.20Mkr -43.86Mkr -40.72Mkr -50.28M
Net Incomekr -36.89Mkr -50.25Mkr -44.05Mkr -40.73Mkr -52.14M
Balance Sheet
Cash & Short-Term Investmentskr 27.39Mkr 16.34Mkr 21.41Mkr 31.11Mkr 49.48M
Total Assetskr 30.16Mkr 19.04Mkr 26.76Mkr 36.68Mkr 52.79M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Net Debtkr -27.39Mkr -16.34Mkr -21.41Mkr -31.11Mkr -49.48M
Total Liabilitieskr 5.22Mkr 5.32Mkr 7.95Mkr 6.53Mkr 6.06M
Stockholders' Equitykr 24.93Mkr 13.71Mkr 18.81Mkr 30.15Mkr 46.73M
Cash Flow
Free Cash Flowkr -37.05Mkr -50.23Mkr -43.40Mkr -41.16Mkr -45.02M
Operating Cash Flowkr -36.92Mkr -50.23Mkr -43.40Mkr -41.16Mkr -45.02M
Investing Cash Flowkr -129.00Kkr 0.00kr 96.00Kkr -260.00Kkr 0.00
Financing Cash Flowkr 48.11Mkr 45.15Mkr 33.61Mkr 23.06Mkr 76.37M
Currency in SEK

Annexin Pharmaceuticals AB Earnings and Revenue History

Income Statement >

Annexin Pharmaceuticals AB Debt to Assets

Balance Sheet >

Annexin Pharmaceuticals AB Cash Flow

Cash Flow >

Annexin Pharmaceuticals AB Forecast EPS vs Actual EPS

Earnings >